TrialGastroenterology2011

The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome.

Philip M Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.